Hennion & Walsh Asset Management, Inc. Jazz Pharmaceuticals PLC Transaction History
Hennion & Walsh Asset Management, Inc.
- $2.35 Billion
- Q2 2025
A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 36,892 shares of JAZZ stock, worth $4.95 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
36,892
Previous 37,802
2.41%
Holding current value
$4.95 Million
Previous $4.69 Million
16.6%
% of portfolio
0.17%
Previous 0.22%
Shares
18 transactions
Others Institutions Holding JAZZ
# of Institutions
562Shares Held
62.4MCall Options Held
563KPut Options Held
77.8K-
Black Rock Inc. New York, NY6.15MShares$825 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.09MShares$818 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.55MShares$343 Million0.65% of portfolio
-
Capital World Investors Los Angeles, CA2.54MShares$342 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.54MShares$341 Million0.06% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $8.41B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...